Respiratory and sleep medicine physicians share collaborative measures to diagnose and treat comorbid sleep disorders and ...

This week, Mad in America examines recent antidepressant research questioning withdrawal severity, a study of unsupported ...

Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage biopharmaceutical company developing innovative combination therapies, today announced that it has been honored with the Research and ...

A nightly oral pill for obstructive sleep apnea is close to regulatory approval in the US. This medicine-based option could transform treatment for millions struggling with device therapies.

REMSleep Holdings, developer of the DeltaWave nasal pillow system, has received expanded 510(k) clearance from the U.S. Food ...

H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering.

Graham Goodrich, CCO, Apnimed, outlines how advances in diagnostics, growing recognition of sleep apnea’s systemic impact, ...

New research shows long-term sleep problems may change gut bacteria, increasing inflammation and health risks beyond the ...

People with sleep disorders share gut microbiome patterns tied to fiber and inflammation, pointing to a possible link between ...

Detailed price information for Incannex Healthcare Inc ADR (IXHL-Q) from The Globe and Mail including charting and trades.

Who doesn't love ice cream? The problem is, ice cream often doesn't love you back. In fact, these are some popular ice cream flavors that are linked to sleep apnea.

DONGGUAN, GUANGDONG, CHINA, January 13, 2026 /EINPresswire.com/ -- As healthcare moves toward proactive and at-home ...